S

Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252

Watchlist Manager
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
Watchlist
Price: 10.62 HKD 2.91% Market Closed
Market Cap: 10.3B HKD
Have any thoughts about
Shanghai MicroPort MedBot Group Co Ltd?
Write Note

Shanghai MicroPort MedBot Group Co Ltd
Cash Interest Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai MicroPort MedBot Group Co Ltd
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
S
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
Cash Interest Paid
ÂĄ17.2m
CAGR 3-Years
712%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shanghai MicroPort MedBot Group Co Ltd
Glance View

Market Cap
10.2B HKD
Industry
Health Care

Shanghai MicroPort MedBot Group Co Ltd is a dynamic player in the medical innovation sector, strategically positioned at the crossroads of advanced technology and healthcare. Born out of a vision to revolutionize surgical practices, MedBot has dedicated itself to the development and commercialization of robotic-assisted systems. The company leverages cutting-edge research and development to create robotic platforms that aid surgeons in performing complex procedures with enhanced precision and control. Operating in a field where precision is paramount, MedBot's products are designed to minimize complications and reduce recovery times, catering to a global demand for improved surgical outcomes. MedBot generates its revenue by selling these sophisticated surgical robots to hospitals and healthcare institutions worldwide. Beyond the initial sale, the company benefits from offering ongoing service contracts, training, and support to ensure seamless integration and optimal performance of their products. Additionally, it capitalizes on the sale of consumables and replacement parts required for the long-term operation of their systems. Through its commitment to innovation and focus on addressing the complexities of surgical procedures, Shanghai MicroPort MedBot Group has carved out a distinctive niche, continually expanding its influence within the expanding scope of minimally invasive surgery.

Intrinsic Value
4.42 HKD
Overvaluation 58%
Intrinsic Value
Price
S

See Also

What is Shanghai MicroPort MedBot Group Co Ltd's Cash Interest Paid?
Cash Interest Paid
17.2m CNY

Based on the financial report for Dec 31, 2023, Shanghai MicroPort MedBot Group Co Ltd's Cash Interest Paid amounts to 17.2m CNY.

What is Shanghai MicroPort MedBot Group Co Ltd's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 3Y
712%

Over the last year, the Cash Interest Paid growth was 61%. The average annual Cash Interest Paid growth rates for Shanghai MicroPort MedBot Group Co Ltd have been 712% over the past three years .

Back to Top